Lourenco Mychael V, Borelli Wyllians Vendramini, Duran-Aniotz Claudia, Zimmer Eduardo R, de Castro Shamyr Sulyvan
Institute of Medical Biochemistry Leopoldo de Meis Federal University of Rio de Janeiro Rio de Janeiro Brazil.
Pharmacology and Therapeutics Research Program Universidade Federal do Rio Grande do Sul (UFRGS) Porto Alegre Brazil.
Alzheimers Dement (N Y). 2023 Mar 22;9(1):e12378. doi: 10.1002/trc2.12378. eCollection 2023 Jan-Mar.
Alzheimer's disease (AD) is a global health issue. Because AD is a condition demanding effective management, its socioeconomic burden is immense and threatens the health systems of both low- and middle-income (LMIC) and high-income (HIC) countries. However, while most of the HICs are increasing their budget for AD research, the situation is different in LMICs, and resources are scarce. In addition, LMIC researchers face significant barriers to publishing in international peer reviewed journals, including funding constraints; language barriers; and in many cases, high article processing charges. In this perspective, we discuss these disparities and propose some actions that could help promote diversity, and ultimately translate into improved AD research capacity in LMICs, especially in Latin American and Caribbean countries.
Researchers in low- and middle-income countries (LMIC) face increasing difficulties such as financial constraints, language barriers, and article processing charges.Publication fees, in particular, can be a significant barrier in the process of publication and equal access to scientific information.Publication fee equalization initiatives by publishing companies could reduce the scientific inequality that disadvantages researchers in LMICs.
阿尔茨海默病（AD）是一个全球性的健康问题。由于AD是一种需要有效管理的疾病，其社会经济负担巨大，对低收入和中等收入国家（LMIC）以及高收入国家（HIC）的卫生系统都构成了威胁。然而，虽然大多数高收入国家正在增加AD研究的预算，但低收入和中等收入国家的情况却不同，资源稀缺。此外，低收入和中等收入国家的研究人员在国际同行评审期刊上发表论文面临重大障碍，包括资金限制、语言障碍；在许多情况下，还有高昂的文章处理费用。从这个角度出发，我们讨论了这些差异，并提出了一些有助于促进多样性的行动，最终转化为提高低收入和中等收入国家，特别是拉丁美洲和加勒比国家的AD研究能力。
低收入和中等收入国家（LMIC）的研究人员面临着越来越多的困难，如资金限制、语言障碍和文章处理费用。特别是出版费用，可能成为出版过程和公平获取科学信息的重大障碍。出版公司的出版费用均等化举措可以减少使低收入和中等收入国家研究人员处于不利地位的科学不平等现象。
